GL1X · GenesisL1 explorer

MolNFT v1 · #33066 · protein

Thrombin inhibitors

2C8Y · Thrombin light chain: “Thrombin inhibitors”. X-ray diffraction, 2 ligands (C3M, NA), 3 pockets (best druggability 0.57). MolNFT v1 #33066 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
2C8Y
Type
protein
Length
290 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Thrombin light chain; Thrombin heavy chain; Hirudin variant-2
EC
3.4.21.5
UniProt
P00734, P09945
Ligands
C3M, NA
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 3 distinct chains · 16% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AThrombin light chain (EC 3.4.21.5)protein2934% helix, 0% strandP00734
BThrombin heavy chain (EC 3.4.21.5)protein25114% helix, 35% strandP00734
IHirudin variant-2protein100% helix, 0% strandP09945

Ligands and binding sites

  • C3M · N-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]naphthalene-2-sulfonamide · ligand · chains B
  • NA · Sodium ion · metal · chains B
  • DMS · Dimethyl sulfoxide · additive · 3 copies · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12900.570.7741DMS, C3M
2900.350.7419empty
3510.320.7713empty

Interfaces

2 interfaces between chains.

  • A–B · 1189 Ų buried · 26 hydrogen bonds · protein-protein
  • B–I · 637 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 2C8Y · thrombin inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.